Peripheral T-cell lymphoma presenting with rapidly progressing myelofibrosis

Leukemia and Lymphoma

Volumn 44, Issue 2, 2003, Pages 361-363

  Uehara, Eisuke ^a   Tasaka, Taizo ^a   Matsuhashi, Yoshiko ^a   Fujita, Mitsuhiro ^a   Tamura, Takahiro ^a   Shimoura, Yasumasa ^a   Mano, Shohei ^a   Kuwajima, Minoru ^b   Nagai, Masami ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Cytokines; Myelofibrosis; Peripheral T cell lymphoma; TGF

Indexed keywords

ANTINEOPLASTIC AGENT; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA;

AGED; ANEMIA; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CAUSE OF DEATH; CELL MATURATION; CELL NUCLEUS; CELL SIZE; CLINICAL FEATURE; DISEASE COURSE; GENE REARRANGEMENT; HEMATOPOIETIC CELL; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INGUINAL LYMPH NODE; LYMPH NODE BIOPSY; LYMPHADENITIS; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MALE; MYELOFIBROSIS; PANCYTOPENIA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SYMPTOMATOLOGY; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE; THROMBOCYTOPENIA;

EID: 0037300497     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000029966     Document Type: Article

References (8)

1. Abe, Y., Ohshima, K., Shiratsuchi, M., Honda, K., Nishimura, J., Nawata, H. and Muta, K. (2001) "Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta", Eur. J. Haematol. 66(3), 210-212.
2. Tefferi, A. (2000) "Myelofibrosis with myeloid metaplasia", N. Engl. J. Med. 342(17), 1255-1265.
3. Nieto, L.H., Raya Sanchez, J.M., Arguelles, H.A., Brito Barroso, M.L. and Gonzalez, B.G. (2000) "A case of chronic lymphocytic leukemia overwhelmed by rapidly progressive idiopathic myelofibrosis", Haematologica 85(9), 973-977.
4. Kimura, A., Katoh, O., Hyodo, H., Kuramoto, A. and Satow, Y. (1995) "Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia", Leuk. Lymphoma 18(3-4), 237-242.
5. Le Bousse-Kerdiles, M.C. and Martyre, M.C. (2001) "Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis", Pathol. Biol. (Paris) 49(2), 153-157.
6. Rameshwar, P., Chang, V.T., Thacker, U.F. and Gascon, P. (1998) "Systemic transforming growth factor-beta in patients with bone marrow fibrosis-pathophysiological implications", Am. J. Hematol. 59(2), 133-142.
7. Le Bousse-Kerdiles, M.C. and Martyre, M.C. (1999) "Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis", Ann. Hematol. 78(10), 437-444.
8. Di Raimondo, F., Azzaro, M.P., Palumbo, G.A., Bagnato, S., Stagno, F., Giustolisi, G.M., Cacciola, E., Sortino, G., Guglielmo, P. and Giustolisi, R. (2001) "Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis", Leukemia 15(6), 976-980.